We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, N.I.H., EXTRAMURAL
RESEARCH SUPPORT, NON-U.S. GOV'T
RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.
Estimating the Causal Effect of Low Levels of Fine Particulate Matter on Hospitalization.
Epidemiology 2017 September
BACKGROUND: In 2012, the EPA enacted more stringent National Ambient Air Quality Standards (NAAQS) for fine particulate matter (PM2.5). Few studies have characterized the health effects of air pollution levels lower than the most recent NAAQS for long-term exposure to PM2.5 (now 12 μg/m).
METHODS: We constructed a cohort of 32,119 Medicare beneficiaries residing in 5138 US ZIP codes who were interviewed as part of the Medicare Current Beneficiary Survey (MCBS) between 2002 and 2010 and had 1 year of follow-up. We considered four outcomes: all-cause hospitalizations, hospitalizations for circulatory diseases and respiratory diseases, and death.
RESULTS: We found that increasing exposure to PM2.5 from levels lower than 12 μg/m to levels higher than 12 μg/m is associated with increases in all-cause admission rates of 7% (95% CI = 3%, 10%) and in circulatory admission hazard rates of 6% (95% CI = 2%, 9%). When we restricted analysis to enrollees with exposure always lower than 12 μg/m, we found that increasing exposure from levels lower than 8 μg/m to levels higher than 8 μg/m increased all-cause admission hazard rates by 15% (95% CI = 8%, 23%), circulatory by 18% (95% CI = 10%, 27%), and respiratory by 21% (95% CI = 9%, 34%).
CONCLUSIONS: In a nationally representative sample of Medicare enrollees, changes in exposure to PM2.5, even at levels consistently below standards, are associated with increases in hospital admissions for all causes and cardiovascular and respiratory diseases. The robustness of our results to inclusion of many additional individual level potential confounders adds validity to studies of air pollution that rely entirely on administrative data.
METHODS: We constructed a cohort of 32,119 Medicare beneficiaries residing in 5138 US ZIP codes who were interviewed as part of the Medicare Current Beneficiary Survey (MCBS) between 2002 and 2010 and had 1 year of follow-up. We considered four outcomes: all-cause hospitalizations, hospitalizations for circulatory diseases and respiratory diseases, and death.
RESULTS: We found that increasing exposure to PM2.5 from levels lower than 12 μg/m to levels higher than 12 μg/m is associated with increases in all-cause admission rates of 7% (95% CI = 3%, 10%) and in circulatory admission hazard rates of 6% (95% CI = 2%, 9%). When we restricted analysis to enrollees with exposure always lower than 12 μg/m, we found that increasing exposure from levels lower than 8 μg/m to levels higher than 8 μg/m increased all-cause admission hazard rates by 15% (95% CI = 8%, 23%), circulatory by 18% (95% CI = 10%, 27%), and respiratory by 21% (95% CI = 9%, 34%).
CONCLUSIONS: In a nationally representative sample of Medicare enrollees, changes in exposure to PM2.5, even at levels consistently below standards, are associated with increases in hospital admissions for all causes and cardiovascular and respiratory diseases. The robustness of our results to inclusion of many additional individual level potential confounders adds validity to studies of air pollution that rely entirely on administrative data.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app